{"id":"https://openalex.org/W2949600157","doi":"https://doi.org/10.1002/hon.18_2632","title":"A WINDOW STUDY OF IXAZOMIB IN UNTREATED B\u2010NHL","display_name":"A WINDOW STUDY OF IXAZOMIB IN UNTREATED B\u2010NHL","publication_year":2019,"publication_date":"2019-06-01","ids":{"openalex":"https://openalex.org/W2949600157","doi":"https://doi.org/10.1002/hon.18_2632","mag":"2949600157"},"language":"en","primary_location":{"id":"doi:10.1002/hon.18_2632","doi":"https://doi.org/10.1002/hon.18_2632","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hon.18_2632","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.18_2632","source":{"id":"https://openalex.org/S23714410","display_name":"Hematological Oncology","issn_l":"0278-0232","issn":["0278-0232","1099-1069"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematological Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.18_2632","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071690547","display_name":"Solomon A. Graf","orcid":"https://orcid.org/0000-0002-9475-3016","observed_orcids":["https://orcid.org/0000-0002-9475-3016"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I2801852214","display_name":"University of Washington Medical Center","ror":"https://ror.org/00wbzw723","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801852214"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S.A. Graf","raw_affiliation_strings":["Medical Oncology, University of Washington, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University of Washington, Seattle, United States","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I2801852214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005281918","display_name":"Ryan C. Lynch","orcid":"https://orcid.org/0000-0001-6703-0894","observed_orcids":["https://orcid.org/0000-0001-6703-0894"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I2801852214","display_name":"University of Washington Medical Center","ror":"https://ror.org/00wbzw723","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801852214"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R.C. Lynch","raw_affiliation_strings":["Medical Oncology, University of Washington, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University of Washington, Seattle, United States","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I2801852214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079426839","display_name":"Chaitra Shankar Ujjani","orcid":"https://orcid.org/0000-0003-1977-1510","observed_orcids":["https://orcid.org/0000-0003-1977-1510","https://orcid.org/0000-0003-2662-4826"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I2801852214","display_name":"University of Washington Medical Center","ror":"https://ror.org/00wbzw723","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801852214"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Ujjani","raw_affiliation_strings":["Medical Oncology, University of Washington, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University of Washington, Seattle, United States","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I2801852214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004667245","display_name":"David Glen Coffey","orcid":"https://orcid.org/0000-0003-3544-8836","observed_orcids":["https://orcid.org/0000-0003-3544-8836"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I2801852214","display_name":"University of Washington Medical Center","ror":"https://ror.org/00wbzw723","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801852214"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D.G. Coffey","raw_affiliation_strings":["Medical Oncology, University of Washington, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University of Washington, Seattle, United States","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I2801852214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088459737","display_name":"Stephen Douglas Smith","orcid":"https://orcid.org/0000-0001-5354-7593","observed_orcids":["https://orcid.org/0000-0001-5354-7593"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I2801852214","display_name":"University of Washington Medical Center","ror":"https://ror.org/00wbzw723","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801852214"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S.D. Smith","raw_affiliation_strings":["Medical Oncology, University of Washington, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University of Washington, Seattle, United States","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I2801852214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051296565","display_name":"Mazyar S. Shadman","orcid":"https://orcid.org/0000-0002-3365-6562","observed_orcids":["https://orcid.org/0000-0002-3365-6562"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I2801852214","display_name":"University of Washington Medical Center","ror":"https://ror.org/00wbzw723","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801852214"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Shadman","raw_affiliation_strings":["Medical Oncology, University of Washington, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University of Washington, Seattle, United States","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I2801852214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064080252","display_name":"Edus Houston Warren","orcid":"https://orcid.org/0000-0002-9570-2755","observed_orcids":["https://orcid.org/0000-0002-9570-2755"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I2801852214","display_name":"University of Washington Medical Center","ror":"https://ror.org/00wbzw723","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801852214"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E.H. Warren","raw_affiliation_strings":["Medical Oncology, University of Washington, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University of Washington, Seattle, United States","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I2801852214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084492085","display_name":"Edward N. Libby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I2801852214","display_name":"University of Washington Medical Center","ror":"https://ror.org/00wbzw723","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801852214"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E.N. Libby","raw_affiliation_strings":["Medical Oncology, University of Washington, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University of Washington, Seattle, United States","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I2801852214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086034320","display_name":"Colin D. Godwin","orcid":"https://orcid.org/0000-0002-6564-9690","observed_orcids":["https://orcid.org/0000-0002-6564-9690"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I2801852214","display_name":"University of Washington Medical Center","ror":"https://ror.org/00wbzw723","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801852214"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Godwin","raw_affiliation_strings":["Medical Oncology, University of Washington, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University of Washington, Seattle, United States","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I2801852214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071844603","display_name":"Ryan Daniel Cassaday","orcid":"https://orcid.org/0000-0002-3424-2425","observed_orcids":["https://orcid.org/0000-0002-3424-2425"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R.D. Cassaday","raw_affiliation_strings":["Hematology, University of Washington, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, University of Washington, Seattle, United States","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023949296","display_name":"Ted Alan Gooley","orcid":"https://orcid.org/0000-0002-8182-3652","observed_orcids":["https://orcid.org/0000-0002-8182-3652"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Gooley","raw_affiliation_strings":["Clinical Research Division, Fred Hutch Cancer Research Center, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutch Cancer Research Center, Seattle, United States","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020858509","display_name":"Jonathan R. Fromm","orcid":"https://orcid.org/0000-0002-2287-5284","observed_orcids":["https://orcid.org/0000-0002-2287-5284"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.R. Fromm","raw_affiliation_strings":["Laboratory Medicine, University of Washington, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory Medicine, University of Washington, Seattle, United States","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004025497","display_name":"Ajay K. Gopal","orcid":"https://orcid.org/0000-0003-3023-6834","observed_orcids":["https://orcid.org/0000-0003-3023-6834"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I2801852214","display_name":"University of Washington Medical Center","ror":"https://ror.org/00wbzw723","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801852214"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A.K. Gopal","raw_affiliation_strings":["Medical Oncology, University of Washington, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University of Washington, Seattle, United States","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I2801852214"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.06568346,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"S2","first_page":"570","last_page":"571"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.7523999810218811,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.7523999810218811,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.24480000138282776,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9010000228881836},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":1.0},{"id":"https://openalex.org/keywords/b-cell-non-hodgkin-lymphoma","display_name":"B-cell non-Hodgkin lymphoma","score":0.8309999704360962},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.7829999923706055},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.8309999704360962},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9409999847412109},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.8960000276565552},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8209999799728394},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7649999856948853},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.4059999883174896},{"id":"https://openalex.org/keywords/resistance-mechanisms","display_name":"resistance mechanisms","score":0.3959999978542328}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8124010562896729},{"id":"https://openalex.org/C2781098529","wikidata":"https://www.wikidata.org/wiki/Q20948663","display_name":"Ixazomib","level":5,"score":0.7196682691574097},{"id":"https://openalex.org/C2781442060","wikidata":"https://www.wikidata.org/wiki/Q425745","display_name":"Bendamustine","level":4,"score":0.6009554266929626},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.5962983965873718},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5584511756896973},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5526576042175293},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.5360187888145447},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.5283159613609314},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.505994975566864},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.46453410387039185},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.4585248529911041},{"id":"https://openalex.org/C2910423619","wikidata":"https://www.wikidata.org/wiki/Q1778287","display_name":"Lymphoplasmacytic Lymphoma","level":4,"score":0.4509713649749756},{"id":"https://openalex.org/C2778563104","wikidata":"https://www.wikidata.org/wiki/Q18553449","display_name":"Marginal zone B-cell lymphoma","level":5,"score":0.43549543619155884},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3455082178115845},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3427913188934326},{"id":"https://openalex.org/C2779921676","wikidata":"https://www.wikidata.org/wiki/Q6760434","display_name":"Marginal zone","level":4,"score":0.2508677840232849},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.23623034358024597},{"id":"https://openalex.org/C2781038049","wikidata":"https://www.wikidata.org/wiki/Q1778287","display_name":"Waldenstrom macroglobulinemia","level":3,"score":0.23592609167099},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.1942598819732666},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1847916543483734},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.1840924620628357},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0},{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/hon.18_2632","doi":"https://doi.org/10.1002/hon.18_2632","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hon.18_2632","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.18_2632","source":{"id":"https://openalex.org/S23714410","display_name":"Hematological Oncology","issn_l":"0278-0232","issn":["0278-0232","1099-1069"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematological Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1002/hon.18_2632","doi":"https://doi.org/10.1002/hon.18_2632","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hon.18_2632","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.18_2632","source":{"id":"https://openalex.org/S23714410","display_name":"Hematological Oncology","issn_l":"0278-0232","issn":["0278-0232","1099-1069"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematological Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Study Protocol","id":"https://openalex.org/study-designs/study-protocol"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2949600157.pdf","grobid_xml":"https://content.openalex.org/works/W2949600157.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2951735615","https://openalex.org/W4409359487","https://openalex.org/W2582857650","https://openalex.org/W2557010481","https://openalex.org/W2523635755","https://openalex.org/W4280502262","https://openalex.org/W2553910750","https://openalex.org/W4310099669","https://openalex.org/W2558511185","https://openalex.org/W2278613621"],"abstract_inverted_index":{"Background:":[0],"Standard":[1],"initial":[2,280],"treatment":[3,14,202],"of":[4,80,93,113,115,136,149,151,192,206,247,263,278,323,328,335,337,347,376],"indolent":[5],"B-cell":[6],"non-Hodgkin":[7,391],"lymphoma":[8,210,392],"(iB-NHL)":[9],"includes":[10],"intravenous":[11],"or":[12,170,213,234],"subcutaneous":[13],"requiring":[15,330],"regular":[16],"infusion":[17],"center":[18],"appointments.":[19],"These":[20],"can":[21],"be":[22,304],"burdensome,":[23],"especially":[24],"for":[25,183,365],"patients":[26,36,81,271],"living":[27],"remotely":[28],"from":[29],"a":[30,72,77,94,104,147,180,225,273,318,326],"cancer":[31],"care":[32],"facility.":[33],"Furthermore,":[34],"most":[35],"with":[37,82,244,258,317,380],"iB-NHL":[38,84],"will":[39,303],"have":[40,146],"survival":[41],"comparable":[42],"to":[43,108,215,267,339,353],"age":[44],"matched":[45],"controls.":[46],"Thus,":[47],"therapies":[48],"that":[49,75,269,296,310],"are":[50,60],"sufficiently":[51],"effective":[52],"and":[53,194,260,325,356,373,424,449],"minimally":[54],"toxic":[55],"while":[56],"being":[57,131,363],"maximally":[58],"convenient":[59],"sought.":[61],"Ixazomib,":[62],"an":[63,185,331],"orally":[64,223],"bioavailable":[65],"proteasome":[66,381],"inhibitor,":[67],"showed":[68],"promising":[69,341],"activity":[70,92,114],"in":[71,98,118,204],"single":[73],"study":[74,107,384],"included":[76,266],"small":[78,167],"number":[79],"relapsed/refractory":[83],"(Assouline":[85],"et":[86],"al.,":[87],"2014).":[88],"As":[89],"the":[90,99,110,134,152,252,297,307,311,370],"maximum":[91],"therapy":[95,275],"is":[96,130,218,265,285,301,315,362,385],"typically":[97],"treatment-na\u00efve":[100],"setting,":[101],"we":[102],"designed":[103],"frontline":[105],"\"window\"":[106],"assess":[109],"potential":[111],"ceiling":[112],"ixazomib":[116],"monotherapy":[117],"iB-NHL.":[119],"Methods:":[120],"This":[121],"single-arm,":[122],"open-label":[123],"investigator-initiated":[124],"phase":[125],"II":[126],"trial":[127],"(NCT":[128],"02339922)":[129],"conducted":[132],"at":[133,220],"University":[135],"Washington":[137],"/":[138,166,173,358],"Fred":[139],"Hutch":[140],"Cancer":[141],"Research":[142,397,406,427,471,504,531],"Center.":[143],"Patients":[144],"must":[145],"diagnosis":[148],"one":[150],"following":[153],"iB-NHL:":[154],"follicular":[155],"lymphoma,":[156,159,162,169],"marginal":[157,208],"zone":[158,209],"mantle":[160],"cell":[161],"chronic":[163],"lymphocytic":[164,168],"leukemia":[165],"Waldenstrom's":[171],"macroglobulinemia":[172],"lymphoplasmacytic":[174],"lymphoma.":[175],"Additional":[176],"eligibility":[177],"criteria":[178],"include":[179,345],"clinical":[181],"indication":[182],"treatment,":[184,355],"Eastern":[186],"Cooperative":[187],"Oncology":[188],"Group":[189],"performance":[190],"status":[191],"\u22642,":[193],"having":[195],"received":[196],"no":[197],"prior":[198],"standard":[199,274],"systemic":[200],"anti-neoplastic":[201],"except":[203],"cases":[205],"mucosa-associated":[207],"relapsed":[211],"after":[212,241],"refractory":[214],"antibiotics.":[216],"Ixazomib":[217,255],"administered":[219],"4":[221],"mg":[222],"once":[224],"week":[226],"on":[227],"consecutive":[228],"28-day":[229],"cycles":[230],"until":[231],"disease":[232],"progression":[233,349],"unacceptable":[235],"toxicity.":[236],"The":[237,282,293,383],"window":[238],"period":[239],"closes":[240],"6":[242],"cycles,":[243],"four":[245],"doses":[246],"weekly":[248],"rituximab":[249,259,264],"added":[250],"during":[251],"7th":[253],"cycle.":[254],"continues":[256],"concurrently":[257],"thereafter.":[261],"Addition":[262],"assure":[268],"all":[270],"receive":[272],"as":[276],"part":[277],"their":[279],"treatment.":[281],"primary":[283],"endpoint":[284],"investigator-assessed":[286],"response":[287,299,313,333],"rate":[288,300,314,322,334],"performed":[289],"every":[290],"2":[291],"cycles.":[292],"null":[294],"hypothesis":[295,309],"true":[298,312],"\u226440%":[302],"tested":[305],"against":[306],"alternative":[308],"\u226560%":[316],"type":[319],"I":[320],"error":[321],"8%":[324],"power":[327],"85%,":[329],"overall":[332],"\u226519":[336],"36":[338],"conclude":[340],"efficacy.":[342],"Secondary":[343],"endpoints":[344],"duration":[346],"response,":[348],"free":[350],"survival,":[351],"time":[352],"next":[354],"safety":[357],"tolerability.":[359],"Tumor":[360],"tissue":[361],"collected":[364],"gene":[366],"expression":[367],"profiling":[368],"using":[369],"NanoString":[371],"platform":[372],"immunohistochemical":[374],"evaluation":[375],"molecular":[377],"pathways":[378],"associated":[379],"inhibition.":[382],"supported":[386],"by":[387],"Takeda":[388],"Oncology.":[389],"Keywords:":[390],"(NHL).":[393],"Disclosures:":[394],"Graf,":[395],"S:":[396,417],"Funding:":[398,407,428,472,505,532],"TG":[399,408,480,538],"Therapeutics,":[400,409,468,481,539],"Acerta":[401,429,483],"Pharma,":[402,484],"BeiGene.":[403],"Lynch,":[404],"R:":[405,487],"Rhizen":[410],"Pharmaceuticals,":[411,454],"Incyte,":[412,507],"Takeda,":[413,537],"Juno":[414],"Therapeutics.":[415],"Smith,":[416],"Consultant":[418,459,494,513],"Advisory":[419,460,495,514],"Role:":[420,461,496,515],"Astrazeneca,":[421,432],"Merck":[422,447],"Sharp":[423,448],"Dohme":[425,450],"Corp.;":[426],"Pharma":[430],"BV,":[431],"Ayala":[433],"(spouse),":[434,438,444],"Bristol":[435],"Myers":[436],"Squibb":[437],"De":[439],"Novo":[440],"Biopharma,":[441,474],"Genentech,":[442,463,478],"Ignyta":[443],"Incyte":[445],"Corporation,":[446],"Corp.,":[451],"Pharmacyclics,":[452,476],"Portola":[453],"Seattle":[455,491,501,516,528],"Genetics.":[456],"Shadman,":[457],"M:":[458],"Abbvie,":[462,479],"Sound":[464],"Biologics,":[465],"Verastem,":[466],"ADC":[467],"Atara":[469],"Biotherapeutics;":[470],"Mustang":[473],"Celgene,":[475],"Gilead,":[477,520],"Beigene,":[482],"Merck.":[485],"Cassaday,":[486],"Employment":[488],"Leadership":[489],"Position:":[490],"Genetics":[492,502],"(spouse);":[493,503],"Amgen,":[497,506,522],"Pfizer;":[498],"Stock":[499],"Ownership:":[500],"Kite/Gilead,":[508],"Merck,":[509,536],"Pfizer.":[510],"Gopal,":[511],"A:":[512],"Genetics,":[517,529],"Pfizer,":[518],"Janssen,":[519],"Spectrum,":[521],"Incyte;":[523],"Honoraria:":[524],"Aptevo,":[525],"BRIM":[526],"Bio,":[527],"Sanofi;":[530],"Teva,":[533],"Bristol-Myers":[534],"Squibb,":[535],"Effector.":[540]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-06-27T00:00:00"}